HIV Diagnosis Market Report

Market Insights

"The global HIV diagnosis market size was estimated at USD 3.73 billion in 2022 and is likely to grow at a CAGR of 9.12% during 2023-2028 to reach USD 6.30 billion in 2028."

Wish to Get a Free Sample? Register Here.

Diagnosis of a blood sample to check the presence of HIV (Human Immunodeficiency Virus) in humans is regarded as an HIV diagnosis. The diagnosis of HIV helps to detect the presence of HIV that causes AIDS (Acquired Immunodeficiency Syndrome). This is carried out by conducting tests on saliva, serum, or urine samples. These tests can detect antigens, antibodies, or RNA.

Market Dynamics

Market Drivers

The market is expected to grow in the coming years due to several factors, including:

• Rising incidence of HIV: The increasing prevalence of HIV/AIDS globally is expected to drive the demand for HIV diagnosis tests.
• Government initiatives: Governments around the world are investing heavily in programs to control the spread of HIV/AIDS, including increased access to testing and treatment. This is likely to increase the demand for HIV diagnosis tests.
• Technological advancements: The development of new diagnostic tests with high accuracy and sensitivity is expected to boost the demand for HIV diagnosis tests.
• Growing awareness: Increased awareness about the importance of early detection and treatment of HIV/AIDS is likely to drive the demand for HIV diagnosis tests.
• The rising number of blood donations & blood transfusions that cause infections is likely to drive the demand for HIV diagnosis tests.
• Recent advancements of simple rapid assays with visual testing coupled with easy-handling home sample collection methods offer lucrative opportunities to the industry players.

Makret Segmentation

Test Trends

"The Antibody Tests Segment accounted for the largest market share and is likely to register a healthy CAGR during the forecast timeline".

The market is segmented into antibody tests, viral identification assays, CD4 testing, viral load testing, and early infant diagnosis. Among these, the Antibody Tests Segment accounted for the largest market share and is likely to register a healthy CAGR during the forecast timeline. This is mainly ascribed to the increasing awareness about HIV, rising technological advancements in HIV diagnosis, and growing blood donations, thereby bolstering segment growth.

Regional Insights

The North American market held the highest market share and is estimated to grow at a steady CAGR during the assessment period. This can be attributed to the presence of a technologically advanced healthcare framework, supportive reimbursement policies, relatively higher healthcare expenditure in research and development, and the high prevalence of HIV thereby proliferating the industry growth in the region.

To know which region offers the best growth opportunities, Click Here.

Key Players

The following are the key players in the HIV diagnosis market (arranged alphabetically).

• Abbott (The U.S.)
• Apogee Flow Systems Ltd. (UK)
• Atomo Diagnostics (Australia)
• BD Biosciences (The U.S.)
• Beckman Coulter Inc. (The U.S.)
• BioMerieux SA (France)
• Cepheid (The U.S.)
• ChemBio Diagnostics Inc. (The U.S.)
• Daktari Diagnostics, Inc. (The U.S.)
• Hologic Inc. (The U.S.)

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Report Features

This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Research Methodology

This strategic assessment report, from Stratview Research, provides a comprehensive analysis that reflects today’s HIV diagnosis market realities and future market possibilities for the forecast period. The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market. The vital data/information provided in the report can play a crucial role for the market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate the growth strategies to expedite their growth process.

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Customization Option

Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players).
• SWOT analysis of key players (up to 3 players).

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.